CHELSEY RUIZ: Open Payments
NPI 1952180259 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 26 payments from 12 companies in 2025. Trend: 2023 $99 · 2024 $496 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Amgen Inc. | 4 | $66 |
| ABBVIE INC. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Lucid Diagnostics Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, VRAYLAR, EVENITY, CAPLYTA, OTEZLA, BYETTA, GVOKE HYPOPEN.
Industry payments across AZ — which companies pay providers there.
